Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia

This study evaluated the efficacy and safety of flecainide in addition to conventional drug therapy in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT). CPVT is an inherited arrhythmia syndrome caused by gene mutations that destabilize cardiac ryanodine receptor Ca(2+) rele...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of the American College of Cardiology Ročník 57; číslo 22; s. 2244
Hlavní autoři:	van der Werf, Christian, Kannankeril, Prince J, Sacher, Frederic, Krahn, Andrew D, Viskin, Sami, Leenhardt, Antoine, Shimizu, Wataru, Sumitomo, Naokata, Fish, Frank A, Bhuiyan, Zahurul A, Willems, Albert R, van der Veen, Maurits J, Watanabe, Hiroshi, Laborderie, Julien, Haïssaguerre, Michel, Knollmann, Björn C, Wilde, Arthur A M
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 31.05.2011
Témata:	Adolescent Adult Aged Anti-Arrhythmia Agents - administration & dosage Anti-Arrhythmia Agents - pharmacology Anti-Arrhythmia Agents - therapeutic use Arrhythmias, Cardiac - prevention & control Child Defibrillators, Implantable Dose-Response Relationship, Drug Exercise Test Female Flecainide - administration & dosage Flecainide - pharmacology Flecainide - therapeutic use Humans Male Middle Aged Polymorphic Catecholaminergic Ventricular Tachycardia Retrospective Studies Tachycardia, Ventricular - drug therapy Young Adult
ISSN:	1558-3597, 1558-3597
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!